標(biāo)題: Titlebook: Biliary Disease; From Science to Clin Gideon Hirschfield,David Adams,Evaggelia Liaskou Book 2017 Springer International Publishing AG 2017 [打印本頁] 作者: Intimidate 時(shí)間: 2025-3-21 16:48
書目名稱Biliary Disease影響因子(影響力)
書目名稱Biliary Disease影響因子(影響力)學(xué)科排名
書目名稱Biliary Disease網(wǎng)絡(luò)公開度
書目名稱Biliary Disease網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Biliary Disease被引頻次
書目名稱Biliary Disease被引頻次學(xué)科排名
書目名稱Biliary Disease年度引用
書目名稱Biliary Disease年度引用學(xué)科排名
書目名稱Biliary Disease讀者反饋
書目名稱Biliary Disease讀者反饋學(xué)科排名
作者: 間接 時(shí)間: 2025-3-21 22:08 作者: 要素 時(shí)間: 2025-3-22 04:26 作者: inflame 時(shí)間: 2025-3-22 08:22 作者: artless 時(shí)間: 2025-3-22 09:07 作者: vitrectomy 時(shí)間: 2025-3-22 14:31
Biliary Atresia: From Pathology to Treatment,l period, and there is no equivalent liver disease outside of this period. It affects all races and ethnic groups, although black mothers are 2.5 times more likely to have a baby with biliary atresia than other ethnic groups. The pathogenesis of biliary atresia is unknown; and research to further un作者: 熱心 時(shí)間: 2025-3-22 20:40
Drug-Induced Cholestasis: Mechanisms and Importance,e of biliary obstruction. Even when the drug responsible for the injury has been discontinued, 7.8% of those with drug-induced cholestasis die; when recovery occurs, it is typically slower in this form of DILI than in hepatocellular cases. Chronicity of cholestasis is reflected by ductopenia on hist作者: Mettle 時(shí)間: 2025-3-22 22:09 作者: Generosity 時(shí)間: 2025-3-23 05:14 作者: 方便 時(shí)間: 2025-3-23 06:44
Cholangiocarcinoma: Disease Pathogenesis and New Treatment Paradigms,s the most common biliary tract malignancy. Most patients are diagnosed with advanced stage disease and are not amenable to potentially curative surgical therapies. The prognosis is dismal with a median survival of <24 months. Novel possible epidemiologic risk factors (i.e., diabetes, cirrhosis, met作者: Resection 時(shí)間: 2025-3-23 13:08 作者: 脆弱帶來 時(shí)間: 2025-3-23 13:58
IgG4-Related Sclerosing Cholangitis,ated disease. Clinically it may mimic other biliary disease, including primary sclerosing cholangitis and cholangiocarcinoma. IgG4-SC may lead to progressive fibrosclerotic disease and cirrhosis. There is no specific test to make the diagnosis, which is based on clinical, laboratory, radiological an作者: CHURL 時(shí)間: 2025-3-23 21:47
Conclusions and Future Opportunities, mortality. The aetiology of the majority of biliary diseases remains unknown so far. Understanding the immunobiological functions played by cholangiocytes in health and disease, developing new animal models that mirror closely human biliary disease, studying the composition of the gut microbiome an作者: 不幸的人 時(shí)間: 2025-3-23 23:58
Gideon Hirschfield,David Adams,Evaggelia LiaskouPresents concise, up-to-date information on diagnosis and management of biliary disease.Explores in detail the relationship between science and clinical practice.Covers the entire spectrum across adul作者: 祝賀 時(shí)間: 2025-3-24 04:28
http://image.papertrans.cn/b/image/186227.jpg作者: 慢跑鞋 時(shí)間: 2025-3-24 07:59 作者: 生氣的邊緣 時(shí)間: 2025-3-24 13:45
Sam Chaudhuri,Peter Stille,Norbert Clauerdimensional structure, encompassing bile ducts of different sizes, morphologies, and functions. The most studied function of biliary epithelial cells (cholangiocytes) is to regulate the hydration and alkalinity of the primary bile secreted by hepatocytes. An increasing number of evidence highlight t作者: reaching 時(shí)間: 2025-3-24 18:32 作者: 滔滔不絕的人 時(shí)間: 2025-3-24 22:46
Developments in Plant and Soil Sciencesality due to the development of biliary type of liver fibrosis, liver cirrhosis, and eventually cholangiocarcinoma [.]. The spectrum of cholangiopathies is heterogeneous with respect to underlying mechanisms, clinical course, and presentation. However, these liver diseases share a common target: the作者: iodides 時(shí)間: 2025-3-25 01:27
https://doi.org/10.1007/978-3-030-99700-7tionship with the gut makes it the primary recipient of degradation products and metabolites originating from the gut. The gut microbiome is therefore important for liver health. The microbiome also has a major influence on bile acid homeostasis, making it particularly relevant for the bile ducts. T作者: ELUDE 時(shí)間: 2025-3-25 03:44 作者: Fierce 時(shí)間: 2025-3-25 11:29
https://doi.org/10.1007/978-3-322-83785-1e of biliary obstruction. Even when the drug responsible for the injury has been discontinued, 7.8% of those with drug-induced cholestasis die; when recovery occurs, it is typically slower in this form of DILI than in hepatocellular cases. Chronicity of cholestasis is reflected by ductopenia on hist作者: 哺乳動(dòng)物 時(shí)間: 2025-3-25 14:55 作者: 平躺 時(shí)間: 2025-3-25 17:07
Full-Wave Effects on Shear-Wave Splitting,clinical association with inflammatory bowel disease. Although rare, PSC harbours a significant and disproportionate clinical need, in which ~50% of patients develop advancing disease necessitating transplantation. These unacceptably poor outcomes highlight a critical therapeutic shortfall in hepato作者: Malfunction 時(shí)間: 2025-3-25 22:05 作者: 自然環(huán)境 時(shí)間: 2025-3-26 02:37 作者: 挑剔為人 時(shí)間: 2025-3-26 07:33 作者: 嗎啡 時(shí)間: 2025-3-26 10:48
Ausgew?hlte volkswirtschaftliche Daten mortality. The aetiology of the majority of biliary diseases remains unknown so far. Understanding the immunobiological functions played by cholangiocytes in health and disease, developing new animal models that mirror closely human biliary disease, studying the composition of the gut microbiome an作者: dithiolethione 時(shí)間: 2025-3-26 15:23 作者: 賠償 時(shí)間: 2025-3-26 17:10
978-3-319-84333-9Springer International Publishing AG 2017作者: 煩人 時(shí)間: 2025-3-26 22:50
https://doi.org/10.1007/978-3-030-99700-7s of diagnosis, disease stage or activity. Furthermore, gut microbiome interventions could theoretically be one means of adjusting the biliary environment. This research field is advancing rapidly and provides hopes of new treatment options in the era of personalized medicine.作者: 鋼筆記下懲罰 時(shí)間: 2025-3-27 02:45 作者: 一罵死割除 時(shí)間: 2025-3-27 07:29
The Microbiome and Human Disease: A New Organ of Interest in Biliary Disease,s of diagnosis, disease stage or activity. Furthermore, gut microbiome interventions could theoretically be one means of adjusting the biliary environment. This research field is advancing rapidly and provides hopes of new treatment options in the era of personalized medicine.作者: Presbyopia 時(shí)間: 2025-3-27 10:21 作者: 博愛家 時(shí)間: 2025-3-27 16:32 作者: neurologist 時(shí)間: 2025-3-27 19:30 作者: 審問 時(shí)間: 2025-3-28 00:17
Conclusions and Future Opportunities,d understanding the genetics of biliary diseases are some of the aspects to be covered in this book. These undergoing efforts will hopefully advance our understanding of how these disorders initiate and develop and will guide future more refined therapeutic approaches.作者: 偶像 時(shí)間: 2025-3-28 05:49 作者: 音樂學(xué)者 時(shí)間: 2025-3-28 06:19
Full-Wave Effects on Shear-Wave Splitting,ent risk. These developments are paralleled by notable pathological discovery, wherein recognition of enteric dysbiosis, essential lymphocyte recruitment pathways, and mucosal immunogenicity have driven a resurgence in clinical trial activity for appropriately stratified patient populations.作者: 提升 時(shí)間: 2025-3-28 13:34 作者: 用不完 時(shí)間: 2025-3-28 15:47 作者: PRISE 時(shí)間: 2025-3-28 19:52
The Clinical Burden of Biliary Disease: A Global Perspective,l curative options, including liver transplantation, to devastating biliary tract cancers with very poor survival. Hopefully, ongoing efforts to elucidate the pathogenesis and define potential targets for therapy for biliary disorders will reduce the burden of these conditions in the future.作者: Blasphemy 時(shí)間: 2025-3-28 23:20
Primary Sclerosing Cholangitis (PSC): Current Concepts in Biology and Strategies for New Therapy,ent risk. These developments are paralleled by notable pathological discovery, wherein recognition of enteric dysbiosis, essential lymphocyte recruitment pathways, and mucosal immunogenicity have driven a resurgence in clinical trial activity for appropriately stratified patient populations.作者: Compatriot 時(shí)間: 2025-3-29 05:08
Cholangiocarcinoma: Disease Pathogenesis and New Treatment Paradigms, factors for all three CCA subtypes, their genetic profile differs. Because knowledge of the genetic landscape of CCA has resulted in multiple new therapeutic strategies and clinical trials, it will become increasingly possible to develop precision medicine-based therapies for CCA patients.作者: 線 時(shí)間: 2025-3-29 09:17
IgG4-Related Sclerosing Cholangitis,hogenesis of IgG4-SC, including the role of HLA class II susceptibility molecules, circulating memory B cells and plasmablasts, T helper 2 and regulatory cells, chemokine-mediated trafficking and the innate immune system.作者: Anticlimax 時(shí)間: 2025-3-29 12:43 作者: Minatory 時(shí)間: 2025-3-29 16:17
Book 2017nces in clinical science may be integrated into current and future therapies. The coverage is wide ranging, encompassing congenital and acquired conditions including cholestatic syndromes, biliary atresia, drug-induced cholestasis, primary biliary cholangitis/cirrhosis, primary sclerosing cholangiti作者: Foam-Cells 時(shí)間: 2025-3-29 23:44
Developments in Plant and Soil Sciencesderation of the most common causes of chronic biliary disease in children and adults. The main emphasis will be on a practical diagnostic approach to the histological assessment of biliary disease – this will include considering the changing role of liver biopsy in the diagnosis and management of patients with biliary disease.作者: 座右銘 時(shí)間: 2025-3-30 03:52 作者: 阻止 時(shí)間: 2025-3-30 05:32 作者: Cumbersome 時(shí)間: 2025-3-30 08:35
and clinical practice.Covers the entire spectrum across adulThis book addresses the current understanding of the diagnosis and management of biliary disease across all ages, with emphasis on how the latest advances in clinical science may be integrated into current and future therapies. The coverage作者: LEVER 時(shí)間: 2025-3-30 14:55 作者: 草本植物 時(shí)間: 2025-3-30 18:05 作者: 是比賽 時(shí)間: 2025-3-30 23:27
Animal Models of Biliary Disease: Current Approaches and Limitations,ble animal models in order to gain insights into the pathophysiology and to test novel therapies. The aim of this chapter is to critically discuss the characteristics and limitations of rodent models of biliary diseases for primary biliary cholangitis, primary sclerosing cholangitis, biliary atresia作者: VOC 時(shí)間: 2025-3-31 04:19
